New method for lipid analysis paves the way for liver cancer treatment

With new methods for studying how diseases and drugs affect the body's lipids, researchers at Uppsala University are taking the next step towards the treatment of liver cancer. “Our results demonstrate the importance of analytical chemistry to the life sciences, but also how important it is that we have the conditions to take our advances further,” says Jenny Nilsson, PhD student at the Department of Medicinal Chemistry.
A multidisciplinary collaboration between Uppsala University and the Uppsala University Hospital is currently focusing on liver cancer – one of the world's deadliest cancers. The aim is to develop better treatment, but achieving this requires tools that provide a more detailed picture of how lipids are affected by disease and treatment. Jenny Nilsson's PhD thesis at the Department of Medicinal Chemistry now takes this work a step further by presenting new methods for analysing changes in the lipidome.

Jenny Nilsson, PhD student at Uppsala University's Department of Medicinal Chemistry
"Lipid molecules are often so similar that they are difficult to distinguish using available methods. In my PhD project, I have developed chromatographic methods that provide important information about lipid structures and how the lipidome changes in disease and following drug administration. The fact that our results have the potential to generate practical benefits is particularly valuable," says Jenny Nilsson, PhD student in Analytical Pharmaceutical Chemistry.
In the first part of her thesis, Jenny Nilsson introduces a method to separate lipids with identical chemical constituents but different structures. In subsequent in vivo studies, Nilsson applies the method to identify changes in lipid profiles following treatment with the cytotoxic drug doxorubicin and/or the cholesterol-lowering drug atorvastatin – results that open up new opportunities for both cancer researchers in Uppsala and other research environments within the life sciences.

Hammertime • Jenny and co-PhDs Chris Mitrogiannis & Matthew Rosenberg nailing theses in style
"Another challenge is that some lipids cause so-called peak tailing in chromatography, which limits the ability to study them in certain chromatographic systems. By adding ammonium bicarbonate, we were able to improve peak symmetry and detectability. This in turn enabled the detection and analysis of several lipid classes – including phosphatidic acid and cardiolipins – demonstrating how crucial the analytical method is for obtaining the answers we are looking for."
Jenny Nilsson's research recently attracted attention at the Lipidomics Forum in Vienna, and at Uppsala Biomedical Center, work is already underway to take the results to the next level. Within the research group, the aim is to shorten the analysis phase, while the observations from the in vivo studies are highly relevant to the cancer project. Several research groups outside Sweden also express interest in implementing the methods in their own research.
"Analytical chemistry is often regarded as a toolbox for other life sciences. The results we are now presenting are yet another demonstration of the importance of our field in developing relevant methods, but also of how important it is that we have the conditions to take our results further. After eleven years at the Faculty of Pharmacy, I know what a fantastic environment we have within Analytical Pharmaceutical Chemistry – and although I will soon be continuing my career at AstraZeneca, I will follow the group's progress with great interest," says Jenny Nilsson.
Facts
- Jenny Nilsson defended her thesis Friday 18 September, 09.15 at BMC, Lecture hall B:42.
- Supervisors were Mikael Hedeland, Curt Pettersson (Uppsala University) and David Balgoma (CSIC-Universidad de Valladolid).
- Opponent at the dissertation was Michal Holčapek (University of Pardubice).
Contact
Jenny Nilsson, PhD student
Department of Medicinal Chemistry
Jenny.M.Nilsson@uu.se
Text: Magnus Alsne, photo: Mikael Wallerstedt a o